Viewing nowCombinationRotacan Tablet 10/8 mg
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
GC Pharma Co., Ltd.

MFDS item code 201702406 · Approved 2017.05.16 · Insurance code 643605400
Treatment of hypertension and heart failure, improvement of dyslipidemia, and suppression of the progression of atherosclerosis and cardiovascular risk
This medication is used for patients who need to take both Candesartan Cilexetil and Rosuvastatin simultaneously. First, Candesartan Cilexetil is used to treat essential hypertension and is also used in patients with heart failure with reduced left ventricular function, who require additional use of ACE inhibitors, or in cases where tolerance to ACE inhibitors is poor. Meanwhile, Rosuvastatin is used as an adjunct therapy for patients whose hypercholesterolemia, particularly primary and familial types, and mixed hyperlipidemia cannot be controlled by diet and exercise. It also helps lower total cholesterol and LDL cholesterol levels in hypercholesterolemic patients, delaying the progression of atherosclerosis, and aids in the dietary management of patients with dysbetalipoproteinemia. Additionally, it reduces the risk of stroke, myocardial infarction, and vascular reintervention in patients at high risk of cardiovascular disease. As a combination of these two drugs, it effectively improves hypertension and hyperlipidemia simultaneously.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil/rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with particular caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue the diet throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate according to LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or longer, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.
This medication may cause serious harm to the fetus if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used by individuals who are allergic to it or its ingredients. Patients with severe liver dysfunction or active liver disease should not take this medication. Women of childbearing potential must use adequate contraception and may only take this medication if the likelihood of pregnancy is low and they have been adequately informed about the risks to the fetus. The use of this medication is contraindicated in patients with certain conditions such as severe liver impairment, myopathy, hereditary angioedema, or severe renal dysfunction. Elderly patients, those with hyperkalemia, and patients with mild liver dysfunction should use this medication with caution and should have regular monitoring of liver enzymes and serum potassium levels during treatment. This medication may cause myalgia or muscle weakness, and in rare cases severe muscle damage (rhabdomyolysis); thus, if any unexplained muscle pain, weakness, or cramps occur during treatment, consult a physician immediately. Extra caution is necessary for patients with a history of muscle disorders, impaired renal function, hypothyroidism, older age, alcohol abuse, or when using certain drugs that increase the risk of muscle damage. Before and during treatment, liver function tests should be conducted, and if liver enzyme levels significantly exceed the normal range, treatment should be discontinued. This medication may increase the risk of hypotension, hyperkalemia, and worsened renal function due to interactions with other antihypertensive agents, diuretics, and potassium-sparing agents; therefore, regular blood pressure and blood tests should be conducted according to a physician’s instructions. This medication may raise blood levels when used with certain drugs, increasing the risk of muscle damage; therefore, inform your doctor or pharmacist about any other medications you are taking. Dizziness, fatigue, and headache may occur during use; caution should be exercised when driving or operating machinery. This medication should be kept out of the reach of children, and it is advisable not to transfer it to another container from the original package.
Headache, nasopharyngitis, localized infection, fatigue, systemic pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, elevated blood glucose, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, dizziness, postural dizziness, milia, periodontitis, inflammation, foreign body sensation, nausea, elevated blood glucose, decreased serum sodium, chest discomfort, musculoskeletal pain, neck pain, cataract, elevated blood glucose, decreased serum sodium, tooth extraction, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, constipation, nausea, abdominal pain, vascular edema, jaundice, hepatitis, liver dysfunction, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, paralysis, hypertonia, syncope, facial flushing, weight gain, facial edema, thirst, sleep disorder, decreased libido, forgetfulness, loss of appetite, increased appetite, tinnitus, taste distortion, erectile dysfunction, hypotension, hyperkalemia, renal impairment, increased creatinine, increased urea, increased potassium, decreased sodium, elevated ALT, elevated AST, elevated γ-GTP, elevated liver enzymes, vascular edema, myalgia, myopathy, rhabdomyolysis, arthralgia, low back pain, renal impairment, acute kidney failure, interstitial pneumonia, shock, syncope, loss of consciousness, weakness, hunger, diaphoresis, hand tremor, decreased concentration, convulsions, altered consciousness, intestinal vascular edema, rash, urticaria, itching, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, severe muscle weakness, ophthalmoplegic weakness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The recommended storage temperature is between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Pink round film-coated tablet
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
GC Pharma Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.